SCHEMBL4973192

SCHEMBL4973192

N#CC1CCN(c2nc(Cl)nc(Cl)c2F)CC1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.36
PDE10A Q9Y233 4/20 0.33
CHRM3 P20309 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
EGLN2 Q96KS0 1/20 0.33
AOC3 Q16853 1/20 0.32
EGLN1 Q9GZT9 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HRH3 Q9Y5N1 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29235105 0.79 ALDH1A1 (0.36) KDM4EALDH1A1PDE10AEGLN2AOC3
SCHEMBL4978816 0.78 JAK2 (0.42) PDE10A
SCHEMBL4975153 0.76 MAOB (0.36) ALDH1A1PDE10ACHRM3PDE4APDE4B
SCHEMBL31553840 0.75 ALDH1A1 (0.34) KDM4EALDH1A1PDE10ACHRM3PDE4A
SCHEMBL25079306 0.75 ALDH1A1 (0.34) KDM4EALDH1A1PDE10ACHRM3PDE4A
SCHEMBL30623545 0.73 EGLN1 (0.34) KDM4EALDH1A1PDE10AEGLN1SMN1; SMN2
SCHEMBL2337541 0.72 SMN1; SMN2 (0.44) KDM4EALDH1A1SMN1; SMN2
SCHEMBL1290498 0.71 ALDH1A1 (0.38) KDM4EALDH1A1PDE10AEGLN2EGLN1
SCHEMBL25240418 0.70 ALDH1A1 (0.34) KDM4EALDH1A1EGLN1SMN1; SMN2HRH3
SCHEMBL25295544 0.70 ALDH1A1 (0.42) KDM4EALDH1A1PDE10ACHRM3PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed